STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5%
Wed, 30 Jan

STRIDES PHARMA SCIENCE has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

STRIDES PHARMA SCIENCE Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m7,4907,3267,9458.4%6.1%
Other incomeRs m157778-89.3%-94.7%
TurnoverRs m7,6477,4047,9537.4%4.0%
ExpensesRs m6,2626,3306,6745.4%6.6%
Gross profitRs m1,1669221,27838.6%9.7%
DepreciationRs m391445407-8.6%4.1%
InterestRs m4984855013.3%0.6%
Profit before taxRs m43470379443.8%-12.6%
TaxRs m-21663293.2%
Profit after taxRs m43554316489.0%-27.5%
Gross profit margin%15.612.616.1
Effective tax rate%-0.423.116.7
Net profit margin%5.70.74.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 6.1% on a year-on-year (YoY) basis. The expenses were up by 6.6% YoY during the same period.
  • The company's operating profit increased by 9.7% YoY during the quarter. Consequently, operating profit margins remained same and stood at 16.1% in 3QFY19.
  • Depreciation charges increased by 4.1% and finance costs increased by 0.6% YoY, respectively.
  • Other income declined by 94.7% YoY during the quarter.
  • Net profit for the quarter declined by 27.5% YoY. Net profit margins during the quarter declined from 5.7% in 3QFY18 to 4.0% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 8.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 5.4% QoQ during the same period.
  • The company's operating profit increased by 38.6% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 16.1% in 3QFY19 as against 12.6% in 2QFY18.
  • Net profit for the quarter increased by 489.0% QoQ, while net profit margins increased from 0.7% in 2QFY18 to 4.0% in 3QFY19.

To see how STRIDES PHARMA SCIENCE has performed over the last eight quarters, please visit here.

STRIDES PHARMA SCIENCE Share Price Performance

Over the last one year, STRIDES PHARMA SCIENCE share price has moved up from Rs 785.6 to Rs 503.7, registering a Loss of Rs 281.9 or around 35.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,736.9 (down 0.2%). Over the last one year it has moved down from 14,799.8 to 13,736.9, a gain of 1,063 points (down 7.2%).

Overall, the S&P BSE SENSEX is down 1.9% over the year.

Current Valuations

At the current price of Rs 503.7, the price to earnings (P/E) ratio of STRIDES PHARMA SCIENCE stands at 72.4 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.2 times.

Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5%". Click here!

  

Related Views on News

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY21); Net Profit Down 46.4% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 621 m (down 46.4% YoY). Sales on the other hand came in at Rs 8 bn (up 13.6% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY21); Net Profit Up 184.5% (Quarterly Result Update)

Aug 20, 2020 | Updated on Aug 20, 2020

For the quarter ended June 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 1 bn (up 184.5% YoY). Sales on the other hand came in at Rs 8 bn (up 14.0% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

More Views on News

Most Popular

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES PHARMA SCIENCE SHARE PRICE


Feb 26, 2021 10:06 AM

TRACK STRIDES PHARMA SCIENCE

  • Track your investment in STRIDES PHARMA SCIENCE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE 8-QTR ANALYSIS

COMPARE STRIDES PHARMA SCIENCE WITH

MARKET STATS